Cogent Biosciences, Inc. Shares Outstanding (Cover Page)
Cogent Biosciences, Inc. (COGT) had Shares Outstanding (Cover Page) of 173.52 million shares as of 2026-08-06, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-06: Entity Common Stock, Shares Outstanding 173.52M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 170.87M shares.
- 2026-02-13: Entity Common Stock, Shares Outstanding 162.31M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 142.38M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 173.52M shares 10-Q · filed 2026-08-10 |
| 2026-05-01 | 170.87M shares 10-Q · filed 2026-05-05 |
| 2026-02-13 | 162.31M shares 10-K · filed 2026-02-17 |
| 2025-11-05 | 142.38M shares 10-Q · filed 2025-11-07 |
| 2025-08-01 | 139.70M shares 10-Q · filed 2025-08-05 |
| 2025-05-02 | 113.86M shares 10-Q · filed 2025-05-06 |
| 2025-02-21 | 113.85M shares 10-K · filed 2025-02-25 |
| 2024-11-08 | 110.46M shares 10-Q · filed 2024-11-12 |
| 2024-08-02 | 109.45M shares 10-Q · filed 2024-08-06 |
| 2024-05-03 | 95.61M shares 10-Q · filed 2024-05-07 |
| 2024-02-22 | 103.91M shares 10-K · filed 2024-02-26 |
| 2023-11-03 | 86.12M shares 10-Q · filed 2023-11-07 |
| 2023-08-04 | 85.47M shares 10-Q · filed 2023-08-08 |
| 2023-05-05 | 70.95M shares 10-Q · filed 2023-05-09 |
| 2023-03-10 | 69.95M shares 10-K · filed 2023-03-14 |
| 2022-11-11 | 69.89M shares 10-Q · filed 2022-11-14 |
| 2022-08-05 | 65.76M shares 10-Q · filed 2022-08-09 |
| 2022-05-06 | 45.82M shares 10-Q · filed 2022-05-10 |
| 2022-03-11 | 45.81M shares 10-K · filed 2022-03-15 |
| 2021-11-08 | 39.85M shares 10-Q · filed 2021-11-10 |
| 2021-08-13 | 39.85M shares 10-Q · filed 2021-08-16 |
| 2021-05-08 | 38.41M shares 10-Q · filed 2021-05-12 |
| 2021-03-12 | 37.19M shares 10-K · filed 2021-03-16 |
| 2020-11-06 | 11.34M shares 10-Q · filed 2020-11-09 |
| 2020-08-07 | 38.26M shares 10-Q · filed 2020-08-11 |
| 2020-05-08 | 31.16M shares 10-Q · filed 2020-05-11 |
| 2020-03-23 | 30.61M shares 10-K · filed 2020-03-26 |
| 2019-11-08 | 30.66M shares 10-Q · filed 2019-11-12 |
| 2019-08-09 | 30.66M shares 10-Q · filed 2019-08-12 |
| 2019-04-30 | 30.12M shares 10-Q · filed 2019-05-13 |
| 2019-02-28 | 30.09M shares 10-K · filed 2019-03-28 |
| 2018-10-31 | 29.99M shares 10-Q · filed 2018-11-13 |
| 2018-07-31 | 29.87M shares 10-Q · filed 2018-08-13 |
| 2018-04-30 | 29.84M shares 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |